Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

GenVec to apply PEDF technology to the treatment of blindness

Feb. 13, 2001

FDA issues approvable letter for Visudyne

Feb. 5, 2001

Clearance sought to begin clinical trials with INS-37217 Ophthalmic

Feb. 2, 2001

Clinical evaluation of Envision TD for DME and posterior uveitis continues

Jan. 26, 2001

New ROCK inhibitor with potential for the treatment of glaucoma licensed out by Welfide

Jan. 25, 2001

Antibacterial eyedrops to be jointly developed by SSP and InSite

Jan. 25, 2001

Allergan obtains rights to compound for PDT of age-related macular degeneration

Jan. 19, 2001

FDA approves study of KeraVision's Intacs inserts trial

Jan. 15, 2001

Aurora Biosciences and Allergan establish ion channel discovery collaboration

Jan. 15, 2001

Inspire's agent for dry eye enters phase III evaluation

Jan. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...